Core Viewpoint - In 2024, Shuyou Shen reported a decline in revenue and an increase in losses, with significant changes in executive compensation structures [1][3]. Financial Performance - The company achieved a revenue of 325 million yuan in 2024, representing a year-on-year decrease of 10.81% compared to 364 million yuan in 2023 [2]. - The net profit attributable to shareholders was -144.84 million yuan, indicating a worsening loss compared to -398.89 million yuan in the previous year, a 63.69% improvement in loss [2]. - Research and development expenses amounted to 162 million yuan, accounting for 49.97% of total revenue, which is a 63.77% decrease from the previous year [1][2]. Product Performance - The product "Shuyouqing" generated sales of 179 million yuan, making up 55.16% of total revenue, down 8.20% year-on-year [2]. - "Sutai" contributed 134 million yuan in sales, representing 41.21% of total revenue, with a decline of 17.30% compared to the previous year [2]. - The product "Shusitong" contributed 7.71 million yuan in revenue after being included in the 2023 National Medical Insurance Directory [2]. Executive Compensation - In 2024, the chairman Zhou Zhiwen received a total pre-tax compensation of 1.1661 million yuan, while the general manager Wang Chao's compensation was 1.5433 million yuan, which is higher than that of the chairman [3][4].